LoQus23 Therapeutics
Pre-clinicalFocuses on developing therapies for Huntington's disease and other repeat expansion disorders.
Founded
2021
Focus
Small Molecules
About
Focuses on developing therapies for Huntington's disease and other repeat expansion disorders.
Funding History
1Total raised: $5.5M
Seed$5.5MAdvent Life SciencesMar 15, 2022
Company Info
TypePrivate
Founded2021
LocationCambridge, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile